Form 8-K - Current report:
SEC Accession No. 0001104659-20-139761
Filing Date
2020-12-28
Accepted
2020-12-28 16:16:00
Documents
11
Period of Report
2020-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039355d1_8k.htm 8-K 31366
2 EXHIBIT 1.1 tm2039355d1_ex1-1.htm EX-1.1 215892
3 EXHIBIT 3.1 tm2039355d1_ex3-1.htm EX-3.1 113871
4 EXHIBIT 4.1 tm2039355d1_ex4-1.htm EX-4.1 14207
5 EXHIBIT 5.1 tm2039355d1_ex5-1.htm EX-5.1 9559
6 EXHIBIT 10.1 tm2039355d1_ex10-1.htm EX-10.1 233750
7 EXHIBIT 10.2 tm2039355d1_ex10-2.htm EX-10.2 144448
8 EXHIBIT 99.1 tm2039355d1_ex99-1.htm EX-99.1 14717
9 EXHIBIT 99.2 tm2039355d1_ex99-2.htm EX-99.2 16156
10 GRAPHIC tm2039355d1_ex99-1img001.jpg GRAPHIC 8043
11 GRAPHIC tm2039355d1_ex99-2img001.jpg GRAPHIC 11327
  Complete submission text file 0001104659-20-139761.txt   822473
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 201418543
SIC: 2834 Pharmaceutical Preparations